A Multi-Center, Prospective, Randomized Trial Comparing the Effectiveness of Aurix Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Description:
Aurix is a platelet-rich plasma gel used in the treatment of non-healing chronic wounds.
Prospective observational studies of the effectiveness of Aurix have demonstrated promising
results in regard to the healing of DFUs, including severe Wagner grade 3 and 4 ulcers. The
aim of this trial is to demonstrate the of complete wound healing in a prospective,
open-label, randomized trial in which diabetic foot ulcers will be treated using Aurix to
determine the time to heal at 12 weeks. Comparison will be made on a 1:1 basis of Aurix + UCC
versus control subjects receiving undefined UCC.
Condition:
Diabetic Foot Ulcers
Treatment:
Aurix
Start Date:
January 2015
Sponsor:
Nuo Therapeutics
For More Information:
https://clinicaltrials.gov/show/NCT02352480